21 devices · GMDN 64209
Tumour‑therapy nanoparticle suspensions for magnetic hyperthermia or thermoablation are injectable liquids that contain super‑paramagnetic iron oxide particles. After being placed directly into a tumour or the tumour cavity, the particles are heated by an externally applied alternating magnetic field to either kill cancer cells directly or make them more vulnerable to radiation or chemotherapy.
These devices are classified as implantable nanomaterials and are regulated based on their intended use for local tumour treatment. They are supplied as sterile aqueous suspensions and must meet safety and performance requirements for both the nanomaterial composition and the magnetic heating process.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.